Dr. Marwa Abozed | Antibiotic | Best Researcher Award

Published on by Infectious

Dr. Marwa Abozed | Antibiotic | Best Researcher Award

Lecturer at Zagazig University Faculty of Human Medicine, Egypt

Marwa Fady Mohamed Abd El Hamed is an esteemed academic and microbiologist whose work extensively focuses on the development and enhancement of antibiotic treatments. With a rich background in pharmaceutical and medical microbiology, she has devoted much of her career to antibiotic-related research including resistance mechanisms and antibiofilm strategies. Her journey through academia and healthcare institutions is consistently guided by her passion for antibiotics, leading to significant contributions in infection control and innovative antimicrobial applications. She consistently demonstrates leadership in advancing knowledge related to antibiotic therapies, both as a scholar and educator. Her roles across institutions in Egypt, Saudi Arabia, and the USA have enriched her expertise and strengthened her resolve to combat the global antibiotic crisis. Her published work clearly reflects her dedication to antibiotic-related innovations, with substantial impact on antifungal, antibacterial, and antibiofilm therapeutic developments. With every academic, clinical, and research role she undertakes, antibiotics remain central to her mission. Her lectures, student guidance, and scientific investigations are deeply intertwined with antibiotic studies, creating a significant footprint in pharmaceutical microbiology. She is widely recognized for her continuous focus on antibiotic innovation, antibiotic resistance, and antibiotic-based natural compounds. Through publications and international conferences, she continues to highlight the critical importance of antibiotics in modern medicine.

Professional Profile 

ORCID

Education

Marwa Fady’s academic background is a testament to her enduring commitment to the field of antibiotics. She earned her Bachelor’s degree in Pharmacy, followed by a Master’s and PhD in Microbiology from Zagazig University. Her graduate and postgraduate work revolved around antibiotic resistance and microbiological investigations of pathogenic strains. Her education incorporated extensive research in antibiotic mechanism, antibiotic synergy, and biofilm inhibition. She later became a visiting scholar at the University of Dayton, USA, where she expanded her focus on global antibiotic challenges. Her degrees serve as a foundation for her life-long pursuit of antibiotic innovations, consistently integrating antibiotics in both theoretical and practical settings. Through every academic milestone, she has maintained a strong emphasis on antibiotic efficacy, antibiotic mechanisms, and antibiotic applications. Her learning journey solidified her expertise in antibiotics, allowing her to contribute to developing next-generation antibiotic solutions. Her thesis and research projects consistently investigated antibiotic-related phenomena, underlining her unwavering academic alignment with antibiotic science. These educational stages nurtured her growth in antibiotic strategies, antibiotic research techniques, and antibiotic policy studies. Her educational path has been deeply intertwined with antibiotics, establishing her as a knowledgeable and credible figure in the antibiotic-focused scientific community.

Experience

Marwa Fady’s professional career has been shaped by her focus on antibiotics in multiple academic and clinical roles. From teaching microbiology and pharmaceutical sciences to managing infection control programs, antibiotics have remained central to her responsibilities. As Assistant Professor at Modern University for Technology and Information, she designs coursework heavily centered on antibiotics, including their classification, resistance mechanisms, and clinical applications. Her tenure at Buraidah Private Colleges and Al-Ghad International Colleges further enriched her hands-on experience in antibiotic research and laboratory practices. During her time in the quality assurance departments, she led efforts in evaluating antibiotic stewardship programs. Her responsibilities included guiding graduation projects with antibiotic research themes, ensuring that antibiotic education remained a priority. As a faculty member at Delta University, she supervised student training in antibiotic susceptibility testing and antibiotic prescription monitoring. She also contributed to infection control initiatives at Zagazig University Hospital, focusing on antibiotic use and evaluation. Across all her professional stations, the common thread is the integration and promotion of antibiotics in teaching, practice, and research. Her career is a dynamic embodiment of antibiotic commitment, and each position she held has contributed to building her legacy in antibiotics-driven academia and clinical microbiology.

Research Interest

Marwa Fady’s primary research interests revolve around antibiotics, particularly in the context of resistance, biofilms, and novel delivery systems. She explores how antibiotics interact with microbial cells and investigates ways to enhance antibiotic efficacy through nanotechnology and natural compounds. Her projects delve into antibiotic resistance in clinical isolates, the identification of antibiofilm agents, and the synthesis of antibiotic-loaded nanocarriers. A significant focus of her research is the modification of antibiotic functionality to overcome microbial resistance and reduce toxicity. She is also interested in discovering natural sources of antibiotics, evaluating plant extracts, and developing formulations that potentiate traditional antibiotics. In addition, her research addresses antibiotic-associated complications in infection control, advocating for rational antibiotic use and promoting antibiotic stewardship. By studying bacteria’s genetic and phenotypic responses to antibiotics, she contributes to understanding resistance development. Her experiments consistently integrate antibiotic testing methods, pharmacokinetics, and synergistic approaches for treatment improvement. Her scientific publications clearly illustrate her unwavering focus on antibiotics, as she bridges microbiology with nanomedicine. Her research not only deepens our knowledge of antibiotics but also supports the creation of advanced antibiotic therapies capable of addressing current global challenges in microbial resistance and public health threats.

Awards and Honors

Marwa Fady has received numerous recognitions for her contributions to antibiotic research and microbiology. Her invitation as a session speaker and poster presenter at various international scientific conferences underlines her expertise in antibiotics. Notably, she represented her antibiotic-related work at the 7th International Conference on Drug Discovery & Therapy in the UAE. Her position as a reviewer for Bentham journals and editorial board member of Frontiers in Environmental Microbiology further acknowledges her credibility in antibiotic-focused publications. She has been repeatedly recognized for her scientific outputs on antibiotics, including antifungal, antibacterial, and antibiofilm activities. These honors reflect her prominence in the field of antibiotic innovation. Her teaching awards and institutional acknowledgments also credit her excellence in antibiotic education and mentorship. Whether through editorial responsibilities or scientific presentations, she has championed the cause of antibiotic advancement. Each award symbolizes a milestone in her antibiotic-centered journey. Her achievements continue to inspire academic and clinical communities in developing new solutions to antibiotic resistance. Marwa Fady's work continues to attract institutional, national, and international recognition, always grounded in the development, improvement, and global application of antibiotics as life-saving therapeutic agents.

Research Skills

Marwa Fady has developed advanced research skills with a clear emphasis on antibiotics, covering experimental design, microbiological techniques, and molecular diagnostics. Her expertise includes culturing resistant strains, evaluating antibiotic susceptibility, and studying biofilm disruption using antibiotics. She is skilled in operating instruments critical for antibiotic analysis, such as microplate readers, incubators, and spectrophotometers. Marwa also masters modern molecular biology tools like PCR, electrophoresis, and genetic sequencing, often applying them to analyze antibiotic resistance genes. Her ability to design and execute in vitro and in vivo studies enables comprehensive evaluations of antibiotic efficacy. She excels in nanomedicine approaches for antibiotic delivery, antibiotic-loaded hydrogel development, and pharmacological assessments. Data interpretation and biostatistical analysis are also part of her skillset, especially in the context of antibiotic resistance trends. She regularly integrates computational tools and in silico modeling to predict antibiotic behaviors. Her research skills reflect her ability to navigate interdisciplinary frameworks involving microbiology, pharmacology, and biotechnology. These competencies have driven the success of numerous antibiotic research projects. Her methodological rigor and innovative outlook make her a key figure in antibiotic discovery and application. Her skills consistently serve the scientific community in addressing antibiotic resistance and refining therapeutic use of antibiotics.

Publications

Title: Chitosan-Based Intelligent Microneedles for Delivery of Amphotericin B Loaded Oleosomes: Antifungal Ocular Patch Targeting for Effective Against Fungal Keratitis Using Rabbit Model via TLR4/NLRP3 Pathway
Author: Marwa Fady
Journal: International Journal of Nanomedicine
Publication Date: 2025-04-30

Title: Polylactic-Co-Glycolic Acid/Alginate/Neem Oil-Reduced Graphene Oxide as a pH-Sensitive Nanocarrier for Hesperidin Drug Delivery: Antimicrobial and Acute Otitis Media Assessments
Authors: Saeed Al Zuhairy, Sammar Fathy Elhabal, Mohamed Fathi Mohamed Elrefai, Sandra Hababeh, Jakline Nelson, Marwa Fady, Nahla A. Elzohairy, Tassneim M. Ewedah, Ibrahim S. Mousa, Ahmed M. Hamdan
Journal: Pharmaceuticals
Publication Date: 2025-03-07

Title: Effect of β-sitosterol on PEL and PSL of Pseudomonas aeruginosa
Authors: Marwa Fady, Y. Irie, R.M. Aljowaie, S. Musaed Almutairi
Journal: Journal of King Saud University - Science
Publication Year: 2024

Title: Enhancing Photothermal Therapy for Antibiofilm Wound Healing: Insights from Graphene Oxide-Cranberry Nanosheet Loaded Hydrogel in vitro, in silico, and in vivo Evaluation
Authors: Sammar Elhabal, Saeed Al Zuhairy, Mohamed El-Nabarawi, Mohamed Elrefai, Mai Shoela, Sandra Hababeh, Jakline Nelson, Mohamed Abdel Khalek, Marwa Fady, Nahla Elzohairy, et al.
Journal: International Journal of Nanomedicine
Publication Date: 2024-12

Title: Evaluation of antibiofilm and cytotoxicity effect of Rumex vesicarius methanol extract
Authors: Marwa Fady, H. Rizwana, K.M. Alarjani, M.A. Alghamdi, S.S. Ibrahim, J. Geyer, A. Abbas
Journal: Open Chemistry
Publication Year: 2023

Title: Efficacy of Ethanol Extract from Leaves Of Malva parviflora to Inhibit Bacterial Biofilm Formation
Authors: Marwa Abozed, Nadia Hashish, Magda Gazer
Journal: Journal of Molecular Biology Research
Publication Date: 2018-04-19

Conclusion

Marwa Fady Mohamed Abd El Hamed is a distinguished researcher whose career is firmly anchored in the study and advancement of antibiotics. Her academic journey, professional practice, and research excellence are harmoniously united by a common goal: improving antibiotic science. Her work not only explores the limits of antibiotic resistance but also proposes novel solutions through nanotechnology and natural compounds. From guiding students in antibiotic-focused courses to publishing breakthrough findings in peer-reviewed journals, her commitment remains unwavering. Marwa’s global exposure and multidisciplinary engagements strengthen her voice in the antibiotic community. Her role as a mentor, speaker, and scholar reinforces the relevance of antibiotics in education, research, and healthcare policy. With each project and publication, she contributes to resolving the global antibiotic crisis, one study at a time. Her vision includes not just understanding antibiotics but also applying them strategically to benefit public health. Her achievements are a testament to how antibiotics can be central to both personal expertise and global innovation. In every capacity—educator, researcher, clinician—antibiotics have guided her mission and continue to define her legacy in microbiology and pharmaceutical science.

Assoc. Prof. Dr. Adelaida Lamas Ferreiro | Antibiotic | Best Researcher Award

Published on by Infectious

Assoc. Prof. Dr. Adelaida Lamas Ferreiro | Antibiotic | Best Researcher Award

Associate Professor at Ramon y Cajal University Hospital, Madrid, Spain

Adelaida Lamas Ferreiro has built a distinguished career in pediatric pulmonology with a focus on cystic fibrosis and infectious respiratory diseases. Throughout her professional timeline, her pioneering efforts in the study and application of Antibiotic therapies have made significant impacts on clinical outcomes. Her leadership in both hospital settings and international consortia has cemented her role in optimizing Antibiotic use in cystic fibrosis care. She has evaluated Antibiotic efficiency in respiratory complications and promoted Antibiotic stewardship in pediatric medicine. With more than 50 clinical trials and academic projects centered on Antibiotic strategies, Adelaida’s research continuously reinforces Antibiotic relevance in managing chronic pulmonary conditions, particularly within vulnerable pediatric populations requiring advanced Antibiotic interventions.

Professional Profile 

Google Scholar

Education

Adelaida Lamas holds a Ph.D. in Medicine and Surgery from Universidad Autónoma de Madrid with academic excellence in pediatric sedation monitoring. Her postgraduate qualifications include a master’s degree in pulmonology unit management and another in clinical hospital administration. From early stages, her education was deeply influenced by studies on Antibiotic action in pulmonary systems. She has pursued extensive training on Antibiotic pharmacodynamics, pharmacokinetics, and Antibiotic mechanisms of resistance. Her international clinical rotations emphasized Antibiotic treatment in cystic fibrosis, reinforcing her expertise in tailoring Antibiotic protocols. Her educational path consistently aligned with evolving Antibiotic research, translating her academic groundwork into high-impact Antibiotic clinical methodologies.

Experience

Dr. Adelaida Lamas has held numerous clinical roles from pediatrician to consultant specialist in cystic fibrosis and pediatric pulmonology. Over three decades, she has directly engaged in Antibiotic regimen development, Antibiotic response analysis, and inpatient/outpatient Antibiotic monitoring. She has collaborated on national Antibiotic protocols and served as a senior advisor for pediatric Antibiotic clinical trials. She spearheaded multidisciplinary teams addressing Antibiotic efficacy in chronic lung infections. Her long-standing presence at the Ramón y Cajal University Hospital included management of patients under high-risk Antibiotic therapies. Her career reflects an unwavering commitment to maximizing Antibiotic utility through evidence-based approaches, influencing global Antibiotic practices.

Research Interest

Adelaida’s research focuses primarily on cystic fibrosis, pediatric lung diseases, and the development of advanced Antibiotic protocols. Her investigative work has examined the influence of inhaled and systemic Antibiotic agents on microbial resistance, with a special interest in Pseudomonas aeruginosa and MRSA strains. She has evaluated biofilm formation suppression using tailored Antibiotic therapies. Her publications address therapeutic challenges posed by Antibiotic resistance in CF patients. Additionally, she explores Antibiotic rotation strategies and novel delivery systems for pediatric populations. Her evolving research underscores Antibiotic relevance in chronic infection modulation, driving forward pediatric pulmonary care innovations via adaptive Antibiotic strategies.

Awards and Honors

Throughout her career, Adelaida has received national and international recognition for her work in Antibiotic research. She was awarded for her contributions to improving Antibiotic application in cystic fibrosis treatment. Her doctoral thesis earned the “Dra. Juana Román First Prize” for excellence in pediatric medicine and Antibiotic safety analysis. She served as principal advisor in the Spanish national Antibiotic positioning reports. As a respected voice in Antibiotic advisory boards and task forces, she influenced policy-making and regulatory evaluations of pediatric Antibiotic use. Her honors reflect a profound contribution to scientific understanding and clinical integration of Antibiotic therapies in respiratory medicine.

Research Skills

Adelaida’s skill set includes designing, conducting, and supervising Antibiotic trials and interventions for pediatric lung diseases. She employs techniques to evaluate Antibiotic resistance, optimize dosage, and analyze pharmacological responses. Her work integrates bioinformatics, molecular diagnostics, and microbiological cultures to assess Antibiotic impact in real time. She is adept in critically appraising clinical literature on Antibiotic therapy and translating findings into bedside protocols. Her proficiency in ethical evaluation of Antibiotic use in vulnerable groups is evident from her role in national ethics committees. These multidisciplinary capabilities solidify her role as a leader in Antibiotic clinical innovation and translational application.

Publications

  • Title: Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
    Authors: P. Mondejar-Lopez, E. Quintana-Gallego, R.M. Giron-Moreno, et al.
    Journal: Respiratory Medicine, Vol. 170, Article 106062, 2020

  • Title: Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis
    Authors: M.C. Megías, O.G. Albarrán, P.G. Vasco, A.L. Ferreiro, L.M. Carro
    Journal: Endocrinología y Nutrición (English Edition), Vol. 62(2), Pages 91–99, 2015

  • Title: A comprehensive evaluation of omega-3 fatty acid supplementation in cystic fibrosis patients using lipidomics
    Authors: Ó. Pastor, P. Guzmán-Lafuente, J. Serna, M. Muñoz-Hernández, A.L. Neyra, et al.
    Journal: The Journal of Nutritional Biochemistry, Vol. 63, Pages 197–205, 2019

  • Title: Protocol for the diagnosis and follow up of patients with cystic fibrosis
    Author: S. Gartner
    Journal: Anales de Pediatría (Barcelona, Spain: 2003), Vol. 71(3), Pages 250–264, 2009

  • Title: Tolerance of two inhaled hypertonic saline solutions in patients with cystic fibrosis
    Authors: L.M. Carro, A.L. Ferreiro, M.R. de Valbuena Maiz, C.W. Struwing, G.G. Álvarez, et al.
    Journal: Medicina Clínica, Vol. 138(2), Pages 57–59, 2012

Conclusion

Adelaida Lamas remains an influential force in pediatric medicine, with her legacy deeply rooted in Antibiotic innovation. Her strategic insights and practical applications of Antibiotic therapies have improved care standards, particularly for cystic fibrosis patients. Her work bridges academic excellence and clinical precision, ensuring Antibiotic efficacy against evolving microbial threats. She is recognized not only for her scientific achievements but also for her mentorship in Antibiotic clinical research. Her enduring contributions ensure the continual advancement of Antibiotic science, affirming its central role in child health and respiratory care. Adelaida’s lifelong dedication to Antibiotic research sets a benchmark for future medical leaders.

Prof. Dr. Hoda Ameen | Plant Pathology | Best Researcher Award

Published on by Infectious

Prof. Dr. Hoda Ameen | Plant Pathology | Best Researcher Award

Prof Researcher at National Research Centre, Egypt

Prof. Hoda Hussein Amin Mohamed has dedicated her career to advancing Plant Pathology, making substantial contributions to nematode control and sustainable agriculture. Her work at the National Research Center emphasizes the importance of Plant Pathology in mitigating plant parasitic threats. Throughout her scientific journey, Plant Pathology has been the cornerstone of her investigations, whether in biological control, nematode resistance, or bio-formulation. Her expertise in Plant Pathology reflects in over four decades of academic and research excellence. Plant Pathology defines her professional ethos, and Plant Pathology continues to inspire her scientific output. Through Plant Pathology, she has transformed knowledge into practical strategies. Plant Pathology remains her lifelong pursuit, and Plant Pathology underpins all her academic and research endeavors in Plant Pathology.

Professional Profile

Orcid | Google Scholar

Education

Her educational foundation in Plant Pathology began at Cairo University, where she obtained her Bachelor, Master's, and Doctorate, all with a strong emphasis on Plant Pathology. Her theses explored biological control and non-chemical resistance in Plant Pathology. The academic depth in Plant Pathology is evident across her curriculum, with courses deeply rooted in Plant Pathology theories and applications. As she progressed academically, Plant Pathology remained central, guiding her learning and practical research. Her Master's and PhD specialized in nematodes within Plant Pathology. This deep academic immersion into Plant Pathology cultivated her future contributions to Plant Pathology. Plant Pathology in every phase defined her education. Plant Pathology has truly shaped her academic perspective through all levels of education.

Experience

Prof. Hoda’s professional experience is immersed in Plant Pathology, from her beginnings as a research assistant to her rise as an Emeritus Research Professor. Her role in the Department of Plant Pathology placed her at the forefront of Plant Pathology-related innovations. Plant Pathology has shaped her responsibilities, achievements, and contributions. She advanced through various ranks by addressing key challenges in Plant Pathology. Her career path is a blueprint for aspiring Plant Pathology professionals. Her administrative leadership as department head further reinforced her Plant Pathology authority. Throughout her employment history, Plant Pathology defined her roles. Plant Pathology dominated her research efforts and shaped her interactions. She remains an exemplar in the domain of Plant Pathology.

Research Interest

Her research interests are wholly aligned with Plant Pathology, focusing extensively on phytoparasitic nematodes and biological control. She has led projects that integrate biotechnology with Plant Pathology strategies. Root-knot nematodes and resistance enhancement dominate her Plant Pathology research spectrum. The dynamics of microbial interaction in Plant Pathology remain one of her deepest passions. Plant Pathology enables her to explore advanced pest management without environmental risks. In Plant Pathology, she innovatively connects genetics, bio-control, and field applications. Plant Pathology continues to frame her experiments, publications, and academic endeavors. Her focus on biotic stress factors underscores her dedication to Plant Pathology. These interests have cemented her legacy in global Plant Pathology research circles.

Award and Honor

Her awards and honors highlight her distinguished service in Plant Pathology. Numerous institutions recognized her outstanding Plant Pathology work in nematode management. Through seminars, conferences, and funded projects, she has been celebrated for her contributions to Plant Pathology. A pioneer in integrating biotechnology into Plant Pathology, she has led award-winning initiatives. Her excellence in Plant Pathology earned her prestigious roles and research leadership positions. Various national and international acknowledgments celebrate her innovative approaches in Plant Pathology. Recognition in Plant Pathology reflects her consistent, impactful engagement in solving global agricultural issues. The academic community applauds her leadership in Plant Pathology. Awards confirm her influence and transformative presence in Plant Pathology.

Research Skill

Her research skills are fundamentally grounded in Plant Pathology, with strengths in nematode diagnosis, microbial biocontrol, and soil health. Plant Pathology methodologies form her analytical core. She applies field, laboratory, and biotechnology techniques, all rooted in Plant Pathology. Her technical expertise covers everything from nematicide development to experimental field trials in Plant Pathology. She mentors scholars on experimental designs in Plant Pathology. Her diagnostic and intervention skills reflect mastery over Plant Pathology challenges. Through data analysis, bio-formulation, and biotic stress evaluation, she exemplifies Plant Pathology excellence. These skills have directly contributed to global Plant Pathology improvements. Her research skillset continues advancing Plant Pathology methods, tools, and field applications.

Publications

Title: Effects and mode of action of some plant extracts on certain plant parasitic nematodes
Authors: A.M. Korayem, S.A. Hasabo, H.H. Ameen
Journal: Anzeiger für Schädlingskunde, Pflanzenschutz, Umweltschutz

Title: Improving the nematicidal potential of Bacillus amyloliquefaciens and Lysinibacillus sphaericus against the root-knot nematode Meloidogyne incognita using protoplast fusion
Authors: M.S. Abdel-Salam, H.H. Ameen, G.M. Soliman, U.S. Elkelany, A.M. Asar
Journal: Egyptian Journal of Biological Pest Control

Title: Efficacy of integrated microorganisms in controlling root-knot nematode Meloidogyne javanica infecting peanut plants under field conditions
Authors: H.A. Osman, H.H. Ameen, M. Mohamed, U.S. Elkelany
Journal: Bulletin of the National Research Centre

Title: In vitro evaluation of some isolated bacteria against the plant parasite nematode Meloidogyne incognita
Authors: G.M. Soliman, H.H. Ameen, S.M. Abdel-Aziz, G.M. El-Sayed
Journal: Bulletin of the National Research Centre

Title: Field control of Meloidogyne incognita and root rot disease infecting eggplant using nematicide, fertilizers, and microbial agents
Authors: H.A. Osman, H.H. Ameen, M. Mohamed, R. El-Mohamedy, U.S. Elkelany
Journal: Egyptian Journal of Biological Pest Control

Conclusion

Prof. Hoda Hussein Amin Mohamed stands as a beacon of innovation and leadership in Plant Pathology. Her career, research, and publications consistently contribute to solving complex Plant Pathology problems. From education to emeritus status, Plant Pathology has guided her journey. Her dedication to Plant Pathology empowers future scientists, shaping the global discourse in Plant Pathology. Plant Pathology has benefited immensely from her expertise. Her influence in Plant Pathology is embedded in policy, academic mentorship, and sustainable agricultural practice. Plant Pathology remains her academic and professional compass. Her impact on Plant Pathology is lasting and expansive. She exemplifies excellence, resilience, and innovation in Plant Pathology today and for generations to come.

Philmon Dejen – scabies – Young Researcher Award

Published on by Infectious

Philmon Dejen - scabies - Young Researcher Award

Debre Berhan University - Ethiopia

AUTHOR PROFILE

ORCID 

🌱 EARLY ACADEMIC PURSUITS

Philmon Dejen Afrasa’s journey in the medical sciences began with an earnest commitment to public health. Born with an innate curiosity about infectious diseases, he pursued a Bachelor of Science degree in Medical Laboratory Technology from Jimma University in 2017. During his undergraduate years, he exhibited a strong interest in parasitic infections, with early research touching upon scabies and other neglected tropical diseases. He further honed his expertise by attaining an MSc in Medical Parasitology from Hawassa University in 2024. His graduate studies coincided with his frontline role during the COVID-19 pandemic, where he led a laboratory technology team, showcasing leadership and technical precision. Philmon’s academic roots laid a solid foundation for his work on scabies, particularly in Ethiopia’s southern regions. His educational journey was not merely about acquiring knowledge—it was a springboard for impactful research on parasitic diseases. Scabies became one of the central themes of his study, as he sought to understand its burden on vulnerable populations. His academic training instilled a commitment to exploring how parasitic infections like scabies intersect with broader public health issues. This early period cultivated a strong scientific ethic and a deep concern for Ethiopia’s endemic disease challenges.

🧪 PROFESSIONAL ENDEAVORS IN PARASITOLOGY

After completing his academic training, Philmon Dejen Afrasa transitioned into a pivotal role as a lecturer and researcher at Debre Berhan University. His professional focus immediately gravitated toward infectious diseases, particularly scabies, malaria, and intestinal parasites. With over five years of experience in medical parasitology, he became a key figure in both academic instruction and community health initiatives. Philmon not only guided future professionals in laboratory diagnostics but also spearheaded public health campaigns that highlighted the impacts of scabies in densely populated and underserved districts. His commitment to applied science was evident in projects such as the ongoing study of intestinal parasites in Hossana Prison and his systemic reviews on Plasmodium falciparum. These efforts illustrated his broad yet focused scope on diseases affecting Ethiopia’s most vulnerable. His investigation into scabies prevalence in Hawassa Zuria was instrumental in identifying risk factors like overcrowding and poor sanitation. As a professional, Philmon balanced his roles as an educator, researcher, and public health advocate. Scabies remained at the core of his work, often serving as a model disease to explore systemic healthcare inequalities. His career reflects a synthesis of academic rigor and humanitarian focus, where scabies became both a subject and a symbol of broader social responsibility.

🔬 RESEARCH FOCUS & SCIENTIFIC CONTRIBUTIONS

Philmon Dejen Afrasa’s research portfolio is a testament to his dedication to parasitic diseases, particularly scabies and malaria. His landmark cross-sectional study published in PLOS ONE provided critical epidemiological data on scabies in Hawassa Zuria, Ethiopia. By examining socioeconomic and environmental determinants, his work brought national attention to an often-neglected condition. His studies go beyond identification and prevalence, offering insights into policy formation and intervention strategies. Philmon has led or participated in six major research projects, including investigations on malaria gene deletions, intestinal parasites, and glucose disorders, each tethered to broader public health implications. Scabies has been a consistent thread, used as a lens to examine healthcare access and community hygiene. His systematic reviews on Plasmodium falciparum gene deletions have implications for malaria diagnosis across Ethiopia, while his work on Anopheles species provides vector control insights. His collaborative efforts with Australian and Ethiopian researchers underscore a growing international footprint. In every study, the presence of scabies either directly or thematically anchors the investigation, reflecting its significance in his research universe. Philmon’s scientific output is small in number but rich in policy relevance, methodological soundness, and real-world application, consistently elevating the visibility of scabies as a research priority.

🏅 ACCOLADES AND RECOGNITION

Philmon Dejen Afrasa’s dedication to parasitic disease research has earned him regional and international recognition. His nomination for the Young Scientist Award by the International Research Awards on Infectious Diseases affirms his growing influence in the medical parasitology field. Although his journal publications are currently limited in number, the depth and public health relevance of his work on scabies have captured the attention of peers and policymakers alike. His leadership during the COVID-19 crisis, where he managed laboratory operations and diagnostic procedures, further highlighted his organizational excellence and earned him institutional commendations. As a member of the Ethiopian Medical Laboratory Association (EMLA) and the Ethiopian Trainers Association (ETA), he contributes to academic dialogues on tropical diseases. The scientific community increasingly cites his findings on scabies prevalence and risk mapping, solidifying his reputation as a researcher of actionable insight. Despite limited publishing output, Philmon’s participation in collaborative international projects, including with researchers in Australia, reinforces the credibility and utility of his research. Scabies remains a focal point in his achievements, recognized as both a scientific and humanitarian concern. His accolades underscore how a singular focus—like scabies—can elevate a researcher's standing and drive meaningful public health interventions.

🌍 IMPACT AND INFLUENCE IN PUBLIC HEALTH

Philmon Dejen Afrasa’s influence extends well beyond academia, touching the lives of thousands in Ethiopia through community-based research and interventions. His investigation into scabies brought to light how overlooked diseases devastate vulnerable populations, particularly in overcrowded and under-resourced districts. His research findings have directly informed local health policies, including hygiene education and targeted treatment campaigns. Philmon’s work on malaria and parasitic infections complements his scabies focus, forming a triad of public health concerns that disproportionately affect Ethiopia’s rural communities. His impact is also felt in correctional health settings, where his ongoing study in Hossana Prison seeks to curb the spread of intestinal parasites. Scabies, as a marker of socio-economic disparity, remains a recurring theme in his advocacy and scholarly output. Through his collaborations and mentorship of young scientists at Debre Berhan University, he fosters a culture of evidence-based practice and community responsiveness. His emphasis on translating research into action ensures that scientific inquiry is not confined to journals but reaches the communities it aims to serve. Scabies research, in particular, has become a platform through which he challenges systemic neglect and promotes equity in healthcare access. His impact exemplifies science in service of humanity.

📚 LEGACY OF TEACHING AND MENTORSHIP

As a lecturer and mentor, Philmon Dejen Afrasa has made a lasting impression on the academic community at Debre Berhan University. His teaching transcends textbook theory, emphasizing real-world application, particularly in parasitology and diagnostic laboratory methods. Students regard him as both a rigorous scientist and a compassionate mentor, especially when discussing diseases like scabies that affect their own communities. Through mentorship, he encourages critical thinking, community engagement, and the ethical pursuit of public health solutions. He has supervised numerous student research projects, many of which examine scabies or other neglected parasitic conditions. His legacy lies not just in his own studies, but in the research he inspires in others. Scabies remains an anchor topic through which he teaches fundamental research skills, epidemiological thinking, and the social determinants of health. His approach is interdisciplinary—integrating public health, laboratory science, and clinical awareness. This blend equips his students to become competent, compassionate professionals. Philmon’s commitment to mentorship helps sustain a new generation of scientists who will continue to explore scabies and similar challenges. Through education, he ensures his influence multiplies, creating a ripple effect that expands the reach of scabies research and strengthens Ethiopia’s healthcare infrastructure for years to come.

🚀 FUTURE CONTRIBUTIONS & GLOBAL VISION

Looking ahead, Philmon Dejen Afrasa envisions a future where neglected diseases like scabies receive the global attention they deserve. His upcoming work includes more comprehensive studies on scabies outbreaks in displaced populations and an expanded collaboration with international research institutions. He also aims to publish a full series on the socio-ecological dimensions of scabies and malaria in Ethiopia, bridging clinical research with anthropological insight. Philmon’s research agenda focuses not only on identifying disease prevalence but also on developing sustainable intervention frameworks. He is currently pursuing funding for a multi-site project across rural Ethiopia to develop community-based treatment and prevention models for scabies and intestinal parasites. As global health continues to emphasize equity, his scabies research will serve as a cornerstone in discussions around marginalized populations and health access. Philmon plans to leverage digital health tools to enhance surveillance and rapid response systems for parasitic outbreaks. He aspires to be a leading voice in shaping Ethiopia’s public health research priorities, ensuring that scabies, among other diseases, is no longer overlooked. His future contributions promise to deepen scientific understanding while transforming public health systems—positioning scabies at the heart of a globally relevant, equity-focused research vision.

NOTABLE PUBLICATION

  • Title: Assessment of scabies and its associated factors in Hawassa Zuria District, Southern Ethiopia: A cross-sectional study

  • Authors: Philmon Dejen, Dereje Oljira Donacho, Mekonnen Girma, Adane Chernet, Susana Vaz Nery, Techalew Shimelis

  • Journal: PLOS ONE

Dr. Pedram Keshavarz | Hepatitis | Best Researcher Award

Published on by Infectious

Dr.Pedram Keshavarz | Hepatitis | Best Researcher Award

Surgery Resident at University of California, Los Angeles (UCLA), United States

Dr. Pedram Keshavarz is an accomplished researcher and clinician with a distinguished academic background and a passion for Hepatitis. His work in radiology, interventional techniques, and artificial intelligence reflects his continued focus on Hepatitis. Through clinical work and academic collaborations, he has elevated the role of imaging in the treatment and diagnosis of Hepatitis. His contributions span major publications, academic presentations, and innovative research on Hepatitis. With Hepatitis being the core of his publications, he contributes significantly to the understanding of Hepatitis mechanisms. From radiologic diagnosis to AI-based prediction, his goal has always been improving Hepatitis patient care. His multidisciplinary expertise uniquely equips him to advance Hepatitis research. Hepatitis remains his enduring priority.

Professional profile

Google Scholar

Education

Dr. Keshavarz earned his MD from Shiraz University of Medical Sciences, grounding his lifelong dedication to Hepatitis. His educational journey was marked by immersion in Hepatitis-focused clinical cases, which enriched his medical knowledge of Hepatitis pathology. During his studies, he published extensively on Hepatitis and completed internships focusing on Hepatitis imaging. His research methodology and diagnostic acumen around Hepatitis developed during this period. His academic credentials reinforce his qualifications in Hepatitis research and Hepatitis patient care. Dr. Keshavarz’s foundation in Hepatitis education continues to influence his Hepatitis studies and Hepatitis diagnostics today. Every stage of his academic career reflects his Hepatitis-focused motivation.

Experience

From serving as a General Surgery Resident at UCLA to being a Post-Doctoral Fellow, Dr. Keshavarz’s professional journey revolves around Hepatitis. At UCLA, he has led projects addressing Hepatitis imaging and AI-modeling in Hepatitis cases. His management of Hepatitis cases during fellowships and observerships provided hands-on insights into Hepatitis pathology. While in Tbilisi, Georgia, he contributed to Hepatitis diagnostics and patient counseling. Each of these roles focused on improving Hepatitis outcomes. His experience spans research, practice, and teaching, each integrated with Hepatitis themes. As a Hepatitis-centered physician, his clinical acumen and academic knowledge converge to drive innovation in Hepatitis.

Research Interest

Dr. Keshavarz's core research interests center on Hepatitis, especially Hepatitis-related hepatocellular carcinoma. He investigates Hepatitis progression through imaging biomarkers and machine learning. His systemic reviews, meta-analyses, and clinical trials contribute to understanding Hepatitis prognosis and Hepatitis treatment outcomes. From ablation therapy to liver transplantation imaging, all his studies explore facets of Hepatitis. Whether using abbreviated MRI or volumetric tumor growth analysis, his focus remains Hepatitis-centered. Hepatitis diagnosis, staging, and therapeutic response prediction define his research direction. His innovation lies in applying AI to decipher complex Hepatitis patterns. Hepatitis has been, and continues to be, the theme of his scientific inquiry.

Award and Honor

Dr. Keshavarz has received numerous awards, all closely tied to his Hepatitis-focused achievements. He received honors from SABI, SIR, and RSNA for his Hepatitis imaging presentations. Notably, his SUMA CUM LAUDE award recognized his Hepatitis biopsy-to-transplant correlation work. His research on Hepatitis recurrence and AI-predicted outcomes earned him the RSNA Trainee Award. Hepatitis was also central to his SIR Foundation Resident Award-winning study. Each accolade reflects his contributions to Hepatitis innovation. The Hepatitis community has celebrated his work for its clinical utility and academic rigor. These honors reflect the value and impact of his Hepatitis investigations. Hepatitis remains his legacy.

Research Skill

Dr. Keshavarz has advanced research skills specialized in Hepatitis-related methodologies. He is proficient in imaging analysis, AI modeling, systematic reviews, and statistical meta-analyses all focused on Hepatitis. His ability to design and conduct Hepatitis trials sets him apart. From tumor segmentation to outcome prediction, he handles complex Hepatitis datasets. His software proficiency supports Hepatitis research at scale. He collaborates effectively across teams focused on Hepatitis, demonstrating leadership and project oversight. His radiologic skill set, fused with data analytics, enables transformative Hepatitis insights. Every research tool he applies serves the goal of improving Hepatitis understanding and treatment. Hepatitis defines his skillset.

Publications

Title: Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
Authors: E. Nichols, J.D. Steinmetz, S.E. Vollset, K. Fukutaki, J. Chalek, F. Abd-Allah, ...
Journal: The Lancet Public Health

Title: Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Authors: V.L. Feigin, B.A. Stark, C.O. Johnson, G.A. Roth, C. Bisignano, G.G. Abady, ...
Journal: The Lancet Neurology

Title: Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Authors: GBD 2019 Stroke Collaborators
Journal: The Lancet Neurology

Title: Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
Authors: V.L. Feigin, B.A. Stark, C.O. Johnson, G.A. Roth, C. Bisignano, G.G. Abady, ...
Journal: The Lancet Neurology

Title: The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Authors: H. Akbari, R. Tabrizi, K.B. Lankarani, H. Aria, S. Vakili, F. Asadian, S. Noroozi, ...
Journal: Life Sciences

Conclusion

In conclusion, Dr. Pedram Keshavarz stands as a prominent figure in Hepatitis research. His academic training, clinical practice, and publication record center entirely around Hepatitis. From radiological diagnosis to machine learning applications, his goal is clear: elevate Hepatitis patient outcomes. With over 50 Hepatitis-focused papers and multiple Hepatitis-related awards, his work has redefined Hepatitis imaging. He actively mentors the next generation in Hepatitis methodology. His ongoing residency and collaborations suggest a future of continued Hepatitis breakthroughs. He is dedicated, capable, and innovative in every aspect of Hepatitis study. Dr. Keshavarz’s contributions form a lasting legacy in the field of Hepatitis.

Sadik Abdulwehab – Infectious Diseases Prevention – Best Researcher Award

Published on by Infectious

Mr.Sadik Abdulwehab | Infectious Diseases Prevention | Best Researcher Award

Wollega University,Nekemte,Ethiopia, Ethiopia

Sadik Abdulwehab Wake is a dedicated academic and clinician with significant contributions in the field of Infectious Diseases Prevention. His work in Infectious Diseases Prevention spans clinical care, teaching, and research. Through focused interventions and evidence-based practices, he has elevated standards in Infectious Diseases Prevention. He has conducted numerous studies revolving around Infectious Diseases Prevention, making Infectious Diseases Prevention a core component of his work. In academic and clinical roles, he integrates Infectious Diseases Prevention methodologies to address public health challenges. His devotion to Infectious Diseases Prevention extends to mentoring and guiding future healthcare professionals, ensuring that Infectious Diseases Prevention remains central. With innovation and compassion, he has become a leader in Infectious Diseases Prevention.

Professional profile

ORCID

Education

Sadik Abdulwehab Wake’s educational path is deeply rooted in Infectious Diseases Prevention. He earned his BSc in Nursing from Wollega University and MSc in Adult Health Nursing from Jimma University, where Infectious Diseases Prevention was a major focus. His graduate work emphasized Infectious Diseases Prevention, enabling him to advance in clinical decision-making and research. Through both degrees, he cultivated a strong foundation in Infectious Diseases Prevention, addressing patient care and academic development. He consistently incorporated Infectious Diseases Prevention principles in coursework and thesis research. His education journey remains an example of how Infectious Diseases Prevention can be integrated into academic excellence and professional advancement.

 Experience    

Sadik Abdulwehab Wake has devoted his career to Infectious Diseases Prevention through clinical and academic work. As a nurse at Nedjo General Hospital ), he applied Infectious Diseases Prevention protocols directly in patient care.  A lecturer at Wollega University, he’s emphasized Infectious Diseases Prevention in teaching and mentorship. His experience demonstrates how Infectious Diseases Prevention informs both clinical and educational settings. His lectures incorporate Infectious Diseases Prevention practices, training the next generation of nurses. His hospital work and university roles are tied together by a consistent focus on Infectious Diseases Prevention, proving his leadership in this field.

Research Interest

Sadik Abdulwehab Wake’s research is driven by Infectious Diseases Prevention, encompassing themes like chronic illness, patient autonomy, cancer care, and telehealth—all with an underlying focus on Infectious Diseases Prevention. He explores innovative methods to advance Infectious Diseases Prevention through systematic reviews and meta-analyses. His investigations often assess how Infectious Diseases Prevention affects care outcomes. He examines barriers and solutions to effective Infectious Diseases Prevention, particularly in Ethiopian healthcare contexts. His work addresses how socio-demographic factors influence Infectious Diseases Prevention efficacy. Whether exploring stroke delay or palliative care gaps, he consistently applies Infectious Diseases Prevention as a research foundation.

Award and Honor

Sadik Abdulwehab Wake has received recognition for his dedication to Infectious Diseases Prevention in both academic and clinical spheres. His publications reflect a commitment to Infectious Diseases Prevention principles, often cited in studies focusing on systemic healthcare improvement. His leadership in Infectious Diseases Prevention has earned respect among peers and mentors. He has been honored for research excellence, particularly in topics relating to Infectious Diseases Prevention, such as HIV care, cancer patient support, and chronic disease adherence. His honors confirm his unwavering investment in Infectious Diseases Prevention and how it shapes the future of global health and policy.

Research Skill

Sadik Abdulwehab Wake possesses diverse research skills, with a sharp focus on Infectious Diseases Prevention. His systematic reviews and meta-analyses exhibit depth in analyzing trends in Infectious Diseases Prevention. He skillfully interprets statistical data related to Infectious Diseases Prevention, producing high-impact publications. From qualitative analysis to survey design, all methodologies center around Infectious Diseases Prevention effectiveness. He evaluates outcomes of Infectious Diseases Prevention in chronic care and develops frameworks for Infectious Diseases Prevention education. His use of SPSS, data synthesis, and clinical trial interpretation demonstrates his technical proficiency in Infectious Diseases Prevention-oriented research.

Publications

  • Title: Deep vein thrombosis in Ethiopia: a systematic review and meta-analysis
    Authors: Sadik Abdulwehab; Frezer Kedir
    Journal: Thrombosis Journal

  • Title: Prehospital delay and associated factors among stroke patients in Africa: A systematic review and meta-analysis
    Authors: Duguma Debela Ganeti; Ilker Kacer; Amanuel Oljira Dulo; Birhanu Wogane Ilala; Nuritu Bacha Benti; Misganu Diriba; Sadik Abdulwehab; Diriba Etana Tola; Lencho Kajela Solbana
    Journal: PLOS One

  • Title: Workplace violence against nurse: a systematic review and meta-analysis in Ethiopia
    Authors: Sadik Abdulwehab; Frezer Kedir
    Journal: BMC Nursing

  • Title: Engagement in healthcare decision-making and associated factors among patients with chronic non-communicable diseases in Southwest Ethiopia, 
    Authors: Sadik Abdulwehab; Yeshitila Belay; Frezer Kedir; Ebrahim Yimam; Admasu Belay
    Journal: Clinical Epidemiology and Global Health

  • Title: Patient autonomy in self-managing their bronchial asthma exacerbation and its associated factors
    Authors: Sadik Abdulwehab; Frezer Kedir
    Journal: Frontiers in Allergy

Conclusion

In conclusion, Sadik Abdulwehab Wake’s career is a testament to how Infectious Diseases Prevention can guide academic, clinical, and research excellence. His integration of Infectious Diseases Prevention in every professional role ensures sustainable healthcare improvement. From hospital floors to university lecture halls, Infectious Diseases Prevention remains his guiding principle. His dedication to Infectious Diseases Prevention reflects in every paper, project, and policy recommendation. As healthcare systems globally pivot toward prevention, his expertise in Infectious Diseases Prevention becomes increasingly vital. His work ensures that Infectious Diseases Prevention is not only studied but actively implemented and sustained.

Kouichi Asahi – Fungal Infections – Excellence in Innovation

Published on by Infectious

Kouichi Asahi - Fungal Infections - Excellence in Innovation

Dokkyo Medical Univiersity Saitama Medical Center - Japan

AUTHOR PROFILE 

ORCID

EARLY JOURNEY IN MEDICAL SCIENCE 🧬

Dr. Kouichi Asahi began his academic journey with a passion for the fundamentals of clinical medicine and a keen interest in diagnostic precision. Earning his M.D. from a prestigious Japanese medical school, he went on to gain board certifications in Internal Medicine, Radiology, and General Practice. From early in his training, Dr. Asahi demonstrated a strong inclination toward the complexities of infectious diseases, especially Fungal Infections. His education laid the foundation for a multidisciplinary approach to diagnosis and care, integrating radiological interpretation with frontline clinical medicine. Dr. Asahi’s academic interests soon gravitated toward how imaging can unearth elusive conditions like invasive Fungal Infections, often misdiagnosed or underrecognized. These challenges inspired him to pursue investigative approaches to the intersection of radiology and mycology. His early academic mentors recognized his deep curiosity and precise analytical thinking—traits that propelled him into complex case studies and rare disease presentations. Throughout his formative years, he participated in research and case evaluations that involved Fungal Infections, helping to establish his long-term commitment to this niche but vital area. These early pursuits cultivated a dedication that would evolve into an influential role in understanding and treating Fungal Infections across clinical domains.

CLINICAL PRACTICE AND RESPONSIBILITY ⚕️

In his dual roles as Vice Director at Kohokuekimae Ohisama Clinic and Attending Physician at Dokkyo Medical University Saitama Medical Center, Dr. Kouichi Asahi exemplifies dedication to patient-centered care. With over a decade of clinical involvement, he has steadily expanded his reach within general medicine and radiology. His practice routinely addresses infectious diseases, with a special emphasis on elusive diagnoses such as Fungal Infections. At the hospital and the community clinic alike, Dr. Asahi is known for methodically identifying complicated cases involving Fungal Infections that mimic other illnesses. He leverages his radiological expertise to pinpoint these infections, often before overt clinical symptoms appear. His daily responsibilities include not only treating patients but also mentoring young clinicians in diagnosing Fungal Infections more accurately. His approach is multidisciplinary, incorporating traditional Japanese Kampo medicine alongside modern therapeutics to manage complex cases. Dr. Asahi’s leadership extends beyond treatment—he is instrumental in guiding protocols for early detection of Fungal Infections, particularly in immunocompromised individuals. His holistic care model bridges technology, tradition, and patient empathy, reinforcing his belief that every medical mystery—especially Fungal Infections—deserves both scientific and humanistic attention. Through his practice, Dr. Asahi continuously enhances awareness and response strategies for Fungal Infections within Japan’s healthcare system.

RESEARCH ON DIAGNOSTIC CHALLENGES 🔬

Dr. Kouichi Asahi’s research trajectory is deeply rooted in solving diagnostic conundrums, especially in the realm of Fungal Infections. His landmark case report on invasive aspergillosis with intracranial extension showcases his acumen in detecting rare fungal pathologies often mistaken for other diseases. This study not only highlighted the complexities of neuroinvasive Fungal Infections but also addressed the common diagnostic pitfalls encountered in internal medicine and radiology. Dr. Asahi uses neuroimaging techniques to distinguish fungal etiologies from granulomatous or neoplastic lesions, making significant contributions to the growing field of radiological mycology. His research draws attention to how subtle radiologic signs can drastically alter treatment outcomes when Fungal Infections are correctly identified. Through his academic work, he encourages the reevaluation of diagnostic frameworks that often overlook fungal etiologies. He also integrates elements of Kampo medicine in research hypotheses, investigating potential synergy between traditional remedies and antifungal strategies. His passion for diagnostic clarity has driven him to publish in reputable journals like J. Fungi, where his findings have influenced both clinical awareness and research directions. Fungal Infections remain central to his investigative endeavors, guiding his efforts to enhance early detection and improve therapeutic accuracy in complex infectious scenarios.

ACADEMIC CONTRIBUTIONS AND PUBLICATIONS 📚

Dr. Asahi’s contributions to medical literature are both precise and impactful, particularly in the study of Fungal Infections. His publication on invasive aspergillosis brought to light a clinically misdiagnosed condition, demonstrating his talent for unraveling subtle but significant clinical narratives. This report emphasized the diagnostic hurdles surrounding Fungal Infections with neurological manifestations and has since been cited as a reference for similar complex cases. Beyond case reporting, Dr. Asahi is deeply involved in academic discussions around imaging interpretation and its role in diagnosing Fungal Infections across different organ systems. His dual expertise in internal medicine and radiology uniquely positions him to present nuanced insights that bridge two critical diagnostic disciplines. He actively contributes to conferences on infectious diseases, where his case studies and imaging interpretations have prompted dialogue on refining fungal diagnostic criteria. His work is not limited to academic journals; he mentors students and residents in clinical research, guiding them in investigating underrepresented infectious cases, particularly Fungal Infections. By transforming clinical experiences into publishable academic material, Dr. Asahi ensures that valuable insights on Fungal Infections reach the wider medical community, contributing to better patient outcomes and enhanced physician awareness worldwide.

INNOVATION IN CLINICAL APPROACHES 💡

Innovation defines Dr. Kouichi Asahi’s methodology in tackling infectious diseases, especially Fungal Infections. He advocates for an integrated diagnostic approach, combining imaging, laboratory findings, and traditional medicine for early identification and personalized treatment of Fungal Infections. Dr. Asahi is a pioneer in incorporating Kampo medicine—Japan’s traditional medical system—with modern pharmacology to enhance treatment outcomes in complex fungal cases. His innovations also extend to protocol development, where he has led initiatives to standardize diagnostic pathways for Fungal Infections in general practice settings. These protocols assist clinicians in recognizing non-specific symptoms that may hint at deep-seated fungal etiologies. His imaging innovations include refined criteria for interpreting CT and MRI scans in the context of suspected Fungal Infections, particularly of the brain and lungs. By aligning technological advancements with traditional diagnostic wisdom, Dr. Asahi has developed a hybrid framework that increases diagnostic confidence. His unique perspective encourages a departure from overly compartmentalized medicine, advocating instead for a systems-based approach to Fungal Infections. His contributions have shaped institutional practices and inspired interdisciplinary collaboration, all rooted in his ongoing commitment to improving outcomes for patients affected by Fungal Infections.

RECOGNITION AND GLOBAL IMPACT 🌍

Dr. Kouichi Asahi’s clinical insight and research excellence have earned him recognition on international platforms. A candidate for the 2025 International Research Awards on Infectious Diseases, Dr. Asahi has distinguished himself through groundbreaking work on Fungal Infections. His research, case presentations, and advocacy have resonated with a global audience seeking advanced diagnostic and therapeutic strategies in mycology. His influence reaches beyond Japan, as he collaborates with international experts in refining protocols for the early detection and management of Fungal Infections. His role as a public relations officer at his clinic also allows him to disseminate essential health information on infectious diseases, including fungal risks, to broader communities. His ability to communicate scientific complexities in accessible language helps bridge gaps between clinical research and public understanding. Dr. Asahi’s recognition extends to his mentorship of junior physicians, whom he trains to consider Fungal Infections more readily in differential diagnoses. His global footprint is not only built on academic merit but also on the meaningful, life-saving impact of his work in the real world. Through teaching, publishing, and innovating, Dr. Asahi continues to redefine how the medical community approaches and responds to Fungal Infections.

FUTURE OUTLOOK AND LEGACY VISION 🔮

Looking ahead, Dr. Kouichi Asahi envisions a healthcare landscape where Fungal Infections are promptly recognized, accurately diagnosed, and effectively treated using interdisciplinary tools. His legacy lies not only in his contributions to diagnostic radiology and internal medicine but also in his consistent focus on Fungal Infections as a growing global concern. He aims to establish a dedicated center for fungal diagnostics in Japan, where imaging technology, laboratory analysis, and traditional medicine converge. Dr. Asahi is also advocating for curriculum revisions in medical schools to include deeper instruction on Fungal Infections, recognizing the gap in awareness among upcoming clinicians. His long-term goals include producing educational resources—both digital and print—that focus on the nuances of identifying and managing fungal diseases. As his mentorship influence grows, so too does his impact on shaping a new generation of clinicians attuned to the complexities of Fungal Infections. Through a career defined by clinical precision, research integrity, and compassionate care, Dr. Asahi is building a legacy that will elevate the global response to fungal threats. His dedication ensures that Fungal Infections remain a medical priority, not just an academic curiosity.

NOTABLE PUBLICATION 

  • Title: Invasive Aspergillosis with Intracranial Extension Initially Misdiagnosed as a Granulomatous Disease: A Case Report
    Author: Kouichi Asahi
    Journal: Journal of Fungi

  • Title: A Case of Refractory Hiccups and Numbness as the Initial Presentation of Multiple Sclerosis
    Author: Kouichi Asahi
    Journal: Cureus

  • Title: Splenic injury with right rib fractures
    Authors: Kouichi Asahi, Jitsuiki K, Takeuchi I, Yoshizawa T, Ishikawa K, Kazuhiko Omori, Hiromichi Ohsaka, Oode Y, Youichi Yanagawa
    Journal: Scholars Journal of Medical Case Reports

  • Title: MR Imaging for Sportology; Non-Invasive Visualization of the Brain and Muscles
    Authors: Shigeki Aoki, Masaaki Hori, Atsushi Nakanishi, Christina Andica, Misaki Nakazawa, Kanako Sato, Kouichi Asahi, Keigo Shimoji
    Journal: Juntendo Medical Journal

  • Title: Transcatheter Arterial Coil Embolization of Ruptured Common Hepatic Artery Aneurysm in a Patient with Behçet’s Disease
    Authors: Akihiro Hotta, Ryohei Kuwatsuru, Kouichi Asahi, Shingo Okada, Daisuke Tsuge, Akihiko Shiraishi, Yoshinari Takasaki
    Journal: Case Reports in Radiology

Ademola Aiyenuro – Pathology – Best Research Article Award

Published on by Infectious

Ademola Aiyenuro - Pathology - Best Research Article Award

University of Cambridge - United Kingdom

AUTHOR PROFILE 

GOOGLE SCHOLAR

ACADEMIC ROOTS & RISING AMBITIONS 🎓

Ademola Emmanuel Aiyenuro’s academic journey is deeply rooted in excellence and a passion for Pathology. After achieving First Class Honours in Microbiology from the Federal University of Technology, Akure, Nigeria, his quest for specialized knowledge led him to the University of Cambridge. There, he pursued an MPhil in Pathology, supported by the HRH Prince of Wales Cambridge Trust Scholarship. His dissertation focused on reserve cells in cervical neoplastic progression, laying the foundation for his later research in cervical cancer biology. Ademola’s dedication to Pathology became further pronounced during his PhD, also at Cambridge, where he focused on immune responses to HPV infections. His academic progress highlights a seamless blend of clinical microbiology, molecular diagnostics, and advanced immunopathological research. Through his training, Ademola mastered critical Pathology techniques like RNAscope, immunofluorescence, and tissue imaging. His understanding of Pathology has not only deepened his technical skills but also shaped his perspective on translational medicine and disease prevention. His strong academic foundations in Pathology continue to support his innovative research endeavors. Across all stages, from undergraduate distinction to doctoral research, Pathology has remained the cornerstone of his scientific evolution, defining both his intellectual identity and his future trajectory in global health research.

PROFESSIONAL ENDEAVORS IN PATHOLOGY 🧪

Ademola Emmanuel Aiyenuro’s professional path has been immersed in the practice of Pathology through a series of hands-on roles. As a PhD candidate in the Department of Pathology at the University of Cambridge, he explored how high-risk HPV types evade immune surveillance in the cervical transformation zone. Using advanced Pathology tools—such as multiplexed antibody panels, immunofluorescence, and confocal microscopy—he deciphered immune exclusion patterns and viral oncogene expression at the single-cell level. In parallel, Ademola contributed as a Research Assistant, analyzing histological samples to assess tissue-specific immune landscapes, further solidifying his expertise in diagnostic and investigative Pathology. Outside academia, his role as a Medical Laboratory Scientist at St. Kizito Clinic exposed him to diagnostic Pathology on the frontlines, conducting microbiological, biochemical, and haematological analyses in HIV and TB patients. These dual roles bridged experimental Pathology with real-world medical diagnostics. Ademola also consulted for MRL® Public Sector Consultants, integrating Pathology-based insights into broader health system reform across Nigeria. This unique fusion of academic and applied Pathology enables him to operate across laboratory research, public health consultancy, and molecular diagnostics. Whether within a Cambridge lab or a Nigerian clinic, Ademola’s commitment to Pathology guides his mission to translate science into patient-centered solutions.

RESEARCH INNOVATION & DISEASE PREVENTION 🔬

Ademola Emmanuel Aiyenuro’s contributions to biomedical science are anchored in his commitment to innovation within Pathology and its application to disease prevention. At the core of his PhD research lies a detailed investigation into cervical precancer recurrence in women living with HIV, employing state-of-the-art Pathology methods to uncover HPV immune evasion mechanisms. His research in Pathology not only identifies molecular drivers of disease but also provides practical frameworks for therapeutic targeting. His co-authored publications—including studies on reserve cells in HPV lesions—have advanced knowledge in viral Pathology and oncogenesis. Ademola’s work has also extended into infectious diseases, where he has contributed to image-based diagnostics for Mpox as a Visiting Researcher at NYU Grossman School of Medicine. In each role, Pathology serves as a diagnostic and prognostic lens through which he dissects disease processes at the cellular and molecular levels. He combines histological insights with computational data curation, ensuring that innovation in Pathology translates into real-world diagnostic improvements. Through literature reviews, grant writing, and peer-reviewed publishing, Ademola amplifies the relevance of Pathology in both academic and clinical discourse. His commitment to precision diagnostics underscores his vision of Pathology not as a static discipline, but as a dynamic engine for global health innovation.

IMPACTFUL ENGAGEMENT IN PUBLIC HEALTH 🌍

A central aspect of Ademola Emmanuel Aiyenuro’s journey has been his integration of Pathology with public health outreach. As a Public Health Officer at Loving Gaze, he spearheaded tuberculosis (TB) detection efforts under Nigeria’s national TB program, utilizing molecular diagnostics rooted in clinical Pathology. He performed GeneXpert testing to detect Mycobacterium tuberculosis and rifampicin resistance—translating Pathology-based diagnostics into high-impact interventions. His work was pivotal in monitoring treatment responses, managing toxicity, and evaluating outcomes using cohort analysis. Beyond diagnostics, Ademola led community-based case findings and health education programs, aligning Pathology-driven insights with behavioral and epidemiological strategies. At HealthDrive Nigeria, his role as a Board Member expanded his outreach by promoting Hepatitis B and C screening and vaccination in underserved communities. His ability to bridge Pathology with health policy and social impact reflects his holistic understanding of disease control. Whether through microscopy or molecular assays, Ademola’s public health initiatives have always returned to the foundational knowledge of Pathology. By linking tissue-level pathology with population-level interventions, he ensures that scientific findings do not remain confined to the lab but drive equitable healthcare access. His career epitomizes how Pathology, when thoughtfully applied, can become a tool for transformative social change.

ADVOCACY, EDUCATION & SCIENTIFIC COMMUNICATION 🗣️

Ademola Emmanuel Aiyenuro’s dedication to Pathology extends far beyond research—it fuels his passion for science education and advocacy. As an academic tutor at the Oxbridge Summer School, he introduced high school students to the fundamentals of genetics and biotechnology, laying early foundations in the life sciences and integrating key concepts from Pathology. In this role, Ademola emphasized the relevance of Pathology in understanding cellular processes and disease mechanisms, inspiring the next generation of biomedical scientists. Through his extensive academic writing and peer-reviewed publishing, Ademola has also become a dynamic science communicator. His publications, such as on HPV-related cervical pathology and COVID-19 diagnostics, have shaped discourse on viral pathogenesis and public health response. Media appearances on Channels TV and TVC News spotlighted his expertise in tuberculosis and malaria control, offering clear, accessible explanations rooted in clinical Pathology. Furthermore, his involvement with policy briefs and stakeholder engagement at MRL® showcases how his scientific communication shapes real-world reforms. Whether teaching young minds or addressing global audiences, Ademola remains a champion of using Pathology as a narrative tool—making science both engaging and empowering. Through his voice, Pathology resonates not only in labs and clinics but also in classrooms, boardrooms, and communities.

HONOURS, MEMBERSHIPS & RECOGNITION 🏅

Recognition of Ademola Emmanuel Aiyenuro’s work in Pathology is evidenced by his numerous awards and affiliations. As a recipient of the prestigious HRH Prince of Wales Cambridge Trust Commonwealth Scholarship, he demonstrated academic distinction in MPhil-level Pathology at Cambridge. His consistent academic excellence also earned him placement on the Dean’s List at the Federal University of Technology, Akure. These accolades underscore his longstanding dedication to Pathology and biomedical research. Ademola's active membership in top-tier professional societies—including the International Papillomavirus Society (IPVS), British Association for Cancer Research (BACR), British Society for Immunology (BSI), and American Society of Microbiology—highlights his global integration within the Pathology and infectious disease community. Through these platforms, he contributes to the advancement of virology, immunopathology, and cancer research. He is not only a participant but also a contributor to international scientific progress, with a voice that extends across symposia, academic publications, and policy frameworks. His awards and memberships affirm his impact, validating Pathology as both his field of specialization and a driver of cross-sectoral collaboration. These recognitions reflect his pursuit of excellence and continued contribution to the future of diagnostic and translational Pathology.

LEGACY & FUTURE DIRECTIONS IN PATHOLOGY 🚀

Ademola Emmanuel Aiyenuro’s vision for the future of Pathology is both ambitious and grounded in a commitment to health equity and scientific advancement. With his multidisciplinary background—spanning diagnostics, immunopathology, microbiology, and public health—he is poised to lead innovative projects that redefine how Pathology informs disease prevention and treatment. His current research on HPV immune control is just the beginning; his expertise positions him to contribute significantly to vaccine development, digital diagnostics, and global infectious disease monitoring. Ademola’s future work may explore the integration of artificial intelligence in histological analysis, expanding the possibilities of computational Pathology. He is also likely to remain active in policy advocacy, ensuring that evidence from Pathology labs informs equitable healthcare delivery, particularly in under-resourced settings like sub-Saharan Africa. Through continued collaboration with academic institutions, government bodies, and non-profit organizations, Ademola will shape a legacy that blends scientific rigor with social relevance. As he mentors young scientists and expands his influence, his contributions will continue to elevate the field of Pathology. His career embodies how focused research, when intertwined with purpose and empathy, can forge lasting impact. Pathology is not merely his specialization—it is his platform for transformative global health leadership.

NOTABLE PUBLICATION

  • Title: Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone
    Authors: J. Doorbar, K. Zheng, A. Aiyenuro, W. Yin, C.M. Walker, Y. Chen, N. Egawa, ...
    Journal: Current Opinion in Virology

 

  • Title: Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria
    Authors: O.A. Abass, V.I. Timofeev, B. Sarkar, D.O. Onobun, S.O. Ogunsola, ...
    Journal: Journal of Biomolecular Structure and Dynamics

 

  • Title: Experiences and projections for drug abuse sensitization and eradication among youths in South West, Nigeria
    Authors: S.O. Ogunsola, E.A. Fajemisin, A.E. Aiyenuro, A.A. Tunde
    Journal: Journal of Alcohol Drug Dependence Substance Abuse

 

  • Title: Antibacterial activity of sorghum “ogi” on diarrhoeagenic Escherichia coli
    Authors: T.T. Adebolu, D.V. Adediwura, E.A. Aiyenuro
    Journal: Journal of Advances in Microbiology

 

  • Title: Neglected Tropical Diseases (NTDs) and COVID-19 pandemic in Africa: Special focus on control strategies
    Authors: A.T. Aborode, E.A. Fajemisin, E.A. Aiyenuro, M.T. Alakitan, M.O. Ariwoola, ...
    Journal: Combinatorial Chemistry & High Throughput Screening

Filip Štrbac – Antibiotics – Best Researcher Award

Published on by Infectious

Filip Štrbac - Antibiotics - Best Researcher Award

University of Belgrade - Institute for Multidisciplinary Research - Serbia

AUTHOR PROFILE 

ORCID
GOOGLE SCHOLAR

EARLY ACADEMIC ROOTS 🌱

Dr. Filip Štrbac’s academic journey in the field of veterinary medicine began with distinction and purpose. Born in Novi Sad, Serbia, his natural aptitude for science was evident during his time at “Jovan Jovanović Zmaj” High School, where he pursued natural sciences and mathematics. This foundation led him to the Faculty of Agriculture at the University of Novi Sad, where he enrolled in the integrated Veterinary Medicine program. Graduating with an impressive GPA of 9.58, his undergraduate thesis explored blood plasma proteins in poultry, showcasing an early interest in biochemistry and physiological processes, both of which intersect with the study of Antibiotics. His passion for veterinary pharmacology and parasitology only deepened as he advanced to doctoral studies. From 2017 to 2023, Dr. Štrbac conducted rigorous research on the anthelmintic efficacy of essential oils, a project intricately linked with the search for plant-based alternatives to conventional Antibiotics. His PhD thesis was not only a scientific contribution to parasitology but also a forward-looking effort to reduce reliance on synthetic Antibiotics in animal health. This pivotal work set the stage for his future investigations into Antibiotics resistance, phytotherapy, and sustainable veterinary interventions—issues central to both public and animal health in the 21st century.

RESEARCH PASSIONS IN VETERINARY SCIENCE 🔬

Dr. Filip Štrbac’s research career is anchored in a multidisciplinary exploration of parasitology, veterinary pharmacology, and phytotherapy—fields deeply connected with the current global discourse on Antibiotics. At the University of Novi Sad and later at the Institute for Multidisciplinary Research in Belgrade, his projects consistently addressed the challenge of Antibiotics resistance by exploring alternatives from nature, particularly essential oils with anthelmintic properties. His groundbreaking in vitro and in vivo studies on gastrointestinal nematodes in sheep examined the pharmacodynamics of plant-based compounds, providing comparative data with traditional Antibiotics. These investigations not only validated the efficacy of natural compounds but also contributed to understanding the mechanisms by which certain pathogens develop resistance to conventional Antibiotics. His collaborative work across European institutions, including research stays in Italy and Spain, enabled a cross-cultural scientific exchange on sustainable veterinary practices. Moreover, his leadership roles in international COST Actions, such as COMBAR and MedPlants4Vet, allowed him to advance studies on minimizing the ecological impact of synthetic Antibiotics. As a result, Dr. Štrbac’s work straddles the boundaries of pharmacology and ecology, advancing veterinary science while actively promoting a global reduction in the use of Antibiotics, thereby contributing to the worldwide effort to curb antimicrobial resistance.

CONTRIBUTIONS TO ANIMAL HEALTH AND THERAPEUTICS 🐑

One of Dr. Filip Štrbac’s most significant contributions lies in his innovative approaches to animal health care, specifically through the development of phytopharmacological strategies that reduce dependence on synthetic Antibiotics. His detailed work on essential oils such as peppermint, oregano, and winter savory demonstrated measurable anthelmintic effects against sheep gastrointestinal nematodes, offering a functional and ecologically safer alternative to traditional Antibiotics. With over ten influential publications in peer-reviewed journals, including Frontiers in Veterinary Science and BMC Veterinary Research, Dr. Štrbac has shaped the veterinary landscape toward sustainable therapeutics. These studies provided compelling evidence of how plant-derived compounds can serve as frontline agents against parasitic infections, particularly in livestock—a sector often overburdened with Antibiotics usage. His interdisciplinary methodology, combining in vitro assays, field trials, and pharmacological modeling, reflects a commitment to scientific rigor and real-world application. Furthermore, his active role in environmental projects such as ENVIRANT underscores his dedication to understanding how Antibiotics affect both treated animals and surrounding ecosystems. Dr. Štrbac’s holistic view of veterinary pharmacology—bridging animal welfare, environmental health, and microbial resistance—positions him as a leader in redefining therapeutic practices beyond conventional Antibiotics-based protocols in veterinary medicine.

GLOBAL COLLABORATIONS AND SCIENTIFIC NETWORKS 🌍

Dr. Filip Štrbac has strategically positioned himself within the global scientific community through active collaboration and leadership in numerous European research networks, focusing on sustainable solutions to challenges posed by overuse of Antibiotics. His work in the COST Actions—such as COMBAR, MedPlants4Vet, ENVIRANT, and BeSafeBeeHoney—has addressed the pressing issue of Antibiotics resistance in livestock systems. By engaging in these consortia, Dr. Štrbac contributed to developing regulatory frameworks and scientific roadmaps for integrating phytotherapeutic alternatives to conventional Antibiotics. His research stays in Spain and Italy, particularly at the University of Naples Federico II and the CREMOPAR Center, were instrumental in aligning Serbian veterinary research with broader EU standards. These exchanges enabled him to co-develop diagnostic protocols and efficacy tests for plant-based treatments in parasitic infections, targeting pathogens commonly treated with Antibiotics. Through these partnerships, he has been a vocal advocate for integrating traditional herbal knowledge with modern veterinary science, a philosophy increasingly seen as vital for reducing overreliance on Antibiotics globally. As an expert evaluator for COST project proposals and a reviewer for high-impact journals in pharmacology and veterinary medicine, he continues to influence how the international community approaches responsible Antibiotics usage, reinforcing a shift toward sustainable, evidence-based parasitic disease control.

SCHOLARSHIP, PUBLICATIONS, AND RECOGNITION 🏅

Dr. Filip Štrbac’s scholarly output reflects both depth and innovation, especially in the context of exploring non-conventional therapies as viable complements or substitutes for Antibiotics. With more than ten peer-reviewed publications focused on essential oils and their pharmacological efficacy, he has emerged as a recognized figure in phytotherapy and veterinary parasitology. His articles often appear in high-impact journals such as Frontiers in Veterinary Science, Veterinary Sciences, and Pakistan Veterinary Journal, where he compares plant-based anthelmintics to standard Antibiotics. The scope of his work includes ovicidal, larvicidal, and adulticidal activities of bioactive compounds, bringing new insights into sustainable parasite control. His excellence has been acknowledged through numerous academic honors, including the Best Student of Generation award and national PhD scholarships funded by the Serbian Ministry of Education. These accolades underscore his scholarly commitment and reflect his aim to address Antibiotics resistance in both national and international contexts. Moreover, his role as a reviewer for leading scientific journals and as an expert evaluator for COST proposals further solidifies his status as a thought leader on alternatives to Antibiotics. Each recognition he has received is a testament to his mission: to challenge traditional paradigms and advance veterinary therapeutics beyond the limits of Antibiotics.

IMPACT ON FUTURE VETERINARY PRACTICE 🚀

Dr. Filip Štrbac’s innovative work has set the foundation for a future in veterinary medicine where sustainability and precision replace dependency on conventional Antibiotics. His research not only expands the therapeutic arsenal with botanically derived anthelmintics but also introduces new frameworks for understanding the ecological implications of prolonged Antibiotics usage. His in vivo trials using essential oils such as oregano and peppermint highlight how natural compounds can achieve comparable or even superior efficacy to traditional Antibiotics without promoting microbial resistance. This groundbreaking evidence supports a paradigm shift in how veterinarians, farmers, and pharmaceutical developers approach parasite management. Through his involvement in multi-national EU projects like eco2adapt and INTACT, Dr. Štrbac promotes the integration of ecosystem-based adaptation into veterinary care, with a special emphasis on minimizing Antibiotics spillover into the environment. His work directly contributes to the One Health movement, bridging human, animal, and environmental health through the reduction of Antibiotics overuse. Future veterinary practitioners, researchers, and policy-makers stand to benefit immensely from the models, data, and strategies he is pioneering. In redefining therapeutic protocols through science-backed phytotherapy, Dr. Štrbac is reshaping the trajectory of global veterinary medicine away from over-reliance on Antibiotics and toward a resilient, sustainable future.

LEGACY AND VISION FOR ANTIBIOTICS ALTERNATIVES 🌿

Dr. Filip Štrbac’s legacy is already being etched into the evolving narrative of modern veterinary pharmacology, especially through his contributions to Antibiotics alternatives. By identifying and validating the therapeutic potential of essential oils and plant extracts, he champions a future where natural remedies complement or replace synthetic Antibiotics in combating parasitic diseases. His vision is deeply aligned with global initiatives targeting antimicrobial resistance, environmental sustainability, and holistic health. As the principal investigator in several international and national projects, Dr. Štrbac continuously advocates for bridging ethnopharmacological traditions with cutting-edge scientific validation. His comprehensive approach—spanning phytochemical analysis, in vivo trials, and regulatory integration—makes his work a blueprint for future Antibiotics research. Beyond his publications and laboratory contributions, his mentorship of young scientists and his engagement in science diplomacy position him as a transformative figure in veterinary medicine. His future goals include expanding phytotherapy databases, developing standardized protocols for plant-based treatments, and influencing policy for regulated, sustainable Antibiotics use. In essence, Dr. Štrbac’s enduring impact will be measured not only by the reduced reliance on Antibiotics but also by the healthier animals, ecosystems, and communities that benefit from his science-driven, nature-inspired approach to veterinary health.

NOTABLE PUBLICATION

  • Title: Anthelmintic resistance in gastrointestinal nematodes of sheep: Current situation and novel strategies
    Authors: Filip Štrbac, Dragica Stojanović
    Journal: Conference Paper – 2024, FeMeSPRumNS

 

  • Title: Physiological role, pharmacokinetics and pharmacodynamics of niacin in cows
    Authors: Kosta Petrović, Dragica Stojanović, Filip Štrbac, Talija Hristovska
    Journal: Conference Paper – 2024, FeMeSPRumNS

 

  • Title: Botanical Control of Parasites in Veterinary Medicine
    Authors: Filip Štrbac, Slobodan Krnjajić, Dragica Stojanović, Nikolina Novakov, Antonio Bosco, Nataša Simin, Radomir Ratajac, Slađan Stanković, Giuseppe Cringoli, Laura Rinaldi
    Journal: Book Chapter – One Health Triad, Vol. III, 2023

 

  • Title: In Vitro and In Vivo Anthelmintic Efficacy of Peppermint (Mentha x piperita L.) Essential Oil against Gastrointestinal Nematodes of Sheep
    Authors: Filip Štrbac, Slobodan Krnjajić, Dragica Stojanović, Radomir Ratajac, Nataša Simin, Dejan Orčić, Laura Rinaldi, Elena Ciccone, Maria Paola Maurelli, Giuseppe Cringoli et al.
    Journal: Frontiers in Veterinary Science – 2023-08-10

 

  • Title: A Potential Anthelmintic Phytopharmacological Source of Origanum vulgare (L.) Essential Oil against Gastrointestinal Nematodes of Sheep
    Authors: Filip Štrbac, Slobodan Krnjajić, Maria Paola Maurelli, Dragica Stojanović, Nataša Simin, Dejan Orčić, Radomir Ratajac, Kosta Petrović, Goran Knežević, Giuseppe Cringoli et al.
    Journal: Animals – 2022-12-22

Jinmin Ma – Hepatitis – Best Researcher Award

Published on by Infectious

Jinmin Ma - Hepatitis - Best Researcher Award

BGI HuoYan Engineering - China

AUTHOR PROFILE

GOOGLE SCHOLAR

EARLY ACADEMIC JOURNEY 🎓

Dr. Jinmin Ma’s academic path laid a strong foundation for his lifelong commitment to advancing global health, particularly in the realm of Hepatitis research. He pursued his education in molecular biomedicine at the University of Copenhagen, Denmark, where he began delving into virology, pathogen-host interactions, and immune responses. His fascination with Hepatitis viruses—especially Hepatitis B and Hepatitis C—grew from these early investigations. Inspired by the burden of Hepatitis on public health worldwide, he focused on the molecular underpinnings of Hepatitis virus survival and replication. During his academic years, he engaged in numerous Hepatitis-related lab projects and developed specialized skills in RNA biology, viral pathogenesis, and molecular virology—all essential for understanding Hepatitis mechanisms. These academic pursuits enabled him to contribute early to the development of molecular detection tools for Hepatitis diagnosis. Even as a student, his drive to confront Hepatitis stood out, foreshadowing a prolific career centered on infectious diseases and Hepatitis. His thesis research on viral genomics offered valuable insight into the mutational patterns and gene expression shifts in Hepatitis. Today, his academic journey remains the cornerstone of his deep-seated expertise in Hepatitis virology. With Hepatitis driving his academic curiosity, Dr. Ma was set on a path to revolutionize the landscape of Hepatitis research.

INNOVATING THROUGH LEADERSHIP 🧬

Dr. Jinmin Ma’s transition from academic scholar to scientific leader marks a remarkable chapter in Hepatitis research. At BGI’s Infectious Disease Department, and later at HuoYan Engineering as Chief Technology Officer, he spearheaded multidisciplinary programs focusing on Hepatitis diagnostics, surveillance, and therapeutic strategies. Under his direction, high-throughput sequencing techniques were optimized to detect and characterize Hepatitis viruses with unprecedented accuracy. His leadership enabled the development of mRNA vaccine platforms targeting Hepatitis B, contributing to global strategies aimed at Hepatitis eradication. His professional milestones include managing grants from the Shenzhen Science and Technology Commission and the China Ministry of Science and Technology—many of which targeted Hepatitis prevention and personalized treatment. Dr. Ma also ensured that Hepatitis remained a top priority in infectious disease conferences and institutional research agendas. His stewardship fostered a dynamic research environment, integrating Hepatitis genomics, proteomics, and transcriptomics. By creating real-time molecular response systems for emerging Hepatitis outbreaks, he elevated public health responses. Dr. Ma’s leadership ensures that Hepatitis remains at the heart of institutional strategy, driving both national and international collaborations focused on Hepatitis control. His vision empowers new generations of researchers to keep Hepatitis prevention and treatment at the forefront of biomedical innovation.

RESEARCH AND DISCOVERY FRONTIERS 🔬

Dr. Jinmin Ma’s research on Hepatitis has significantly advanced our understanding of viral pathogenesis and host responses. His work encompasses over 80 publications, many centered on Hepatitis B and Hepatitis C virus biology. He was among the first to characterize genotype switching in Hepatitis B as a potential risk factor for vertical transmission. His studies revealed critical mechanisms by which Hepatitis viruses evade host immunity, contributing to chronic infection and liver damage. Through metagenomic sequencing and mRNA-based diagnostics, Dr. Ma has enhanced early detection strategies for Hepatitis, particularly in resource-limited settings. One of his landmark publications demonstrated how Hepatitis B virus (HBV) mutations affect viral persistence, adding depth to HBV evolutionary studies. His research also delved into transcriptomic profiling of Hepatitis-infected individuals, uncovering host immune suppression pathways. This led to the identification of novel biomarkers for disease staging and treatment efficacy. Dr. Ma has actively explored Hepatitis co-infections with other pathogens such as HIV and tuberculosis, assessing their synergistic effects on disease severity. He champions personalized medicine approaches tailored to Hepatitis genotypes and patient immune profiles. As Hepatitis remains a pressing global issue, Dr. Ma’s innovations continue to shape the future of Hepatitis diagnostics, therapeutics, and vaccine development.

IMPACT IN INFECTIOUS DISEASES 🌍

Few researchers have made such a comprehensive impact in infectious diseases as Dr. Jinmin Ma, especially in the context of Hepatitis. His scientific influence spans diverse domains—from molecular virology to public health policy—all unified by a central goal: to control and eliminate Hepatitis. He has played a vital role in reshaping national guidelines on Hepatitis surveillance through his integration of metatranscriptomic technologies. During the COVID-19 pandemic, he contributed to pandemic preparedness by applying Hepatitis research frameworks to RNA virus containment strategies. His tools for Hepatitis detection have been adapted for broader infectious disease surveillance, exemplifying cross-application of technologies. By working with multidisciplinary teams across genomics, immunology, and epidemiology, Dr. Ma has built comprehensive systems for Hepatitis outbreak response. He often emphasizes the interconnectedness of Hepatitis with social and economic determinants, advocating for equitable access to Hepatitis screening and treatment. His research has led to the implementation of molecular panels that detect multiple pathogens—including Hepatitis viruses—in a single assay. Through these efforts, he’s helped reduce the burden of Hepatitis-related liver disease in several regions. Dr. Ma’s holistic approach ensures that Hepatitis remains not only a research priority but also a cornerstone of modern infectious disease control strategies.

ACHIEVEMENTS AND ACCOLADES 🏅

Dr. Jinmin Ma’s contributions to Hepatitis research have earned him widespread recognition. He was honored as a Reserve Talent of High-Level Professional in Shenzhen, a testament to his pioneering work in Hepatitis virus surveillance and vaccine innovation. Numerous grants from the Shenzhen Science and Technology Commission and China’s Ministry of Science and Technology supported his Hepatitis-related breakthroughs. His publication record, boasting over 13,000 citations and an H-index of 14, highlights the global resonance of his Hepatitis-focused studies. As a reviewer for esteemed journals like The Lancet Respiratory Medicine and EClinicalMedicine, he evaluates cutting-edge research, often emphasizing Hepatitis virology. Dr. Ma’s editorial leadership for Frontiers in Cellular and Infection Microbiology has shaped special issues that highlight Hepatitis and co-infection dynamics. His accolades reflect a career devoted to translating Hepatitis science into life-saving technologies. He has also patented Hepatitis-related diagnostic systems, including methods for metagenomic classification and host immune profiling. These accolades not only honor individual achievement but also highlight the broader significance of Hepatitis research in the 21st century. As recognition of his work grows, so does the potential for Hepatitis control on a global scale. Through awards and impact, Dr. Ma keeps the fight against Hepatitis in sharp scientific and societal focus.

GLOBAL COLLABORATIONS AND KNOWLEDGE SHARING 🤝

Dr. Jinmin Ma’s Hepatitis research transcends borders, fostering a global network of scientific exchange. His collaborative projects with institutions in Europe, Southeast Asia, and Africa center around molecular epidemiology of Hepatitis viruses. These partnerships aim to standardize Hepatitis surveillance, especially in regions with high prevalence and limited diagnostic capacity. By organizing and contributing to international workshops, Dr. Ma disseminates the latest innovations in Hepatitis sequencing, resistance tracking, and vaccine design. His work with the University of Copenhagen and global virology consortia facilitates comparative analysis of Hepatitis strains across populations. He has also trained numerous junior researchers in techniques crucial to Hepatitis monitoring, such as mRNA quantification, droplet digital PCR, and metagenomics. This knowledge transfer accelerates Hepatitis eradication goals in resource-challenged areas. Dr. Ma ensures that Hepatitis research remains inclusive and collaborative, uniting virologists, clinicians, and data scientists under a shared mission. His joint publications on Hepatitis genotype shifts, co-infection with tuberculosis, and antiviral responses emphasize shared responsibility in public health. These efforts exemplify his belief that Hepatitis is a global issue requiring united scientific effort. Through cross-border collaboration, Dr. Ma elevates the standard and reach of Hepatitis research, ensuring knowledge translates into action worldwide.

LEGACY IN MOLECULAR VIROLOGY 🧪

Dr. Jinmin Ma’s legacy is firmly etched in the field of molecular virology, with Hepatitis at its center. He redefined approaches to studying Hepatitis virus structure, replication, and immune interaction by integrating bioinformatics and next-generation sequencing. His insights into Hepatitis B virus genome dynamics, including genotype switching and intra-host variability, are widely cited and referenced. His research showed how specific mutations in the Hepatitis B X gene could influence vertical transmission risks, a revelation that reshaped pediatric hepatology. Dr. Ma developed multi-pathogen diagnostic platforms that include sensitive detection for Hepatitis strains, making viral diagnostics more comprehensive. He also contributed to the early adoption of mRNA vaccine platforms tailored to Hepatitis control, influencing current vaccine strategies. His advocacy for real-time Hepatitis data analytics has improved outbreak forecasting models. Beyond bench science, his mentorship of early-career scientists has cultivated a new generation of Hepatitis researchers. Many of his trainees now lead their own Hepatitis-focused labs. Dr. Ma’s legacy isn’t confined to publications or patents—it lives in institutional frameworks and global dialogues on Hepatitis control. Through decades of persistent innovation, his molecular virology legacy cements Hepatitis as both a scientific challenge and a public health priority.

FUTURE VISIONS FOR HEPATITIS CONTROL 🚀

Looking ahead, Dr. Jinmin Ma envisions a world where Hepatitis is no longer a global health threat. He continues to push scientific boundaries by advancing ultra-rapid diagnostic tools that can detect emerging Hepatitis variants within hours. His current research explores personalized Hepatitis vaccines using real-time transcriptomic data to tailor immune responses. He is also piloting artificial intelligence models that predict Hepatitis treatment outcomes based on genetic and epigenetic signatures. These next-gen tools could revolutionize how we manage Hepatitis in both endemic and non-endemic regions. Dr. Ma advocates for stronger integration of Hepatitis diagnostics into routine healthcare systems, especially in underserved areas. He’s also proposing cloud-based surveillance platforms to share Hepatitis data across national borders in real time. As climate change alters viral transmission patterns, Dr. Ma is studying how environmental shifts impact Hepatitis epidemiology. Through strategic collaborations, he hopes to bring affordable and scalable Hepatitis interventions to communities worldwide. His future plans include establishing a dedicated Hepatitis Innovation Hub within BGI to consolidate research, training, and implementation efforts. Dr. Ma’s forward-looking approach ensures that Hepatitis remains a solvable challenge through science, collaboration, and dedication. His vision inspires a new era in Hepatitis prevention, treatment, and global elimination efforts.

NOTABLE PUBLICATION

  • Title: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
    Authors: R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, ...
    Journal: The Lancet, Vol. 395 (10224), pages 565–574, 2020

  • Title: Selection of reference genes for quantitative real-time PCR in bamboo (Phyllostachys edulis)
    Authors: C. Fan, J. Ma, Q. Guo, X. Li, H. Wang, M. Lu
    Journal: PLOS ONE, Vol. 8 (2), e56573, 2013

  • Title: Dominant subtype switch in avian influenza viruses during 2016–2019 in China
    Authors: Y. Bi, J. Li, S. Li, G. Fu, T. Jin, C. Zhang, Y. Yang, Z. Ma, W. Tian, J. Li, S. Xiao, ...
    Journal: Nature Communications, Vol. 11 (1), Article 5909, 2020

  • Title: Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children
    Authors: Y. Li, X. Fu, J. Ma, J. Zhang, Y. Hu, W. Dong, Z. Wan, Q. Li, Y.Q. Kuang, K. Lan, ...
    Journal: Nature Communications, Vol. 10 (1), Article 2288, 2019

  • Title: Sequence recombination and conservation of Varroa destructor virus-1 and deformed wing virus in field collected honey bees (Apis mellifera)
    Authors: H. Wang, J. Xie, T.G. Shreeve, J. Ma, D.W. Pallett, L.A. King, R.D. Possee
    Journal: PLOS ONE, Vol. 8 (9), e74508, 2013